OGVFAP 2026, held on 14-15/5 in TP HCM, drew nearly 3,000 experts, doctors, and researchers. The event gathered dozens of leading professors from the UK, the US, France, Australia, Singapore, and other countries, fostering a multidisciplinary exchange of knowledge. As a sponsor, DKT Mekong provided resources and contributed modern medical technology solutions, supporting the Vietnamese medical community in updating new advancements.
 |
DKT Mekong's booth at OGVFAP 2026. Photo: DKT Mekong
At its exhibition booth, DKT Mekong showcased its superior product portfolio. These products are the result of rigorous clinical research, aimed at ensuring maximum user safety and improving the quality of medical services.
The highlight at DKT Mekong's booth was its new-generation intrauterine device (IUD) product line. The company utilizes silver core technology and geometric design improvements to ensure high contraceptive efficacy and minimize side effects. These products meet all international verification standards, providing a long-term physical health protection solution for women.
 |
DKT Mekong's intrauterine device (IUD) product. Photo: DKT Mekong
Additionally, DKT Mekong's reproductive health solutions also stand out for their strict adherence to World Health Organization (WHO) standards. By integrating advancements in safety and efficacy, these solutions empower women to actively manage their motherhood journey.
As a non-governmental organization, DKT Mekong has consistently provided quality solutions at reasonable costs for decades, making them accessible to the vast majority of people. "Participating in OGVFAP 2026 is an important step for us to achieve larger public health goals in Southeast Asia, aiming for sustainable development in reproductive healthcare", a DKT Mekong representative stated.
 |
DKT Mekong staff demonstrating the use of an intrauterine device (IUD) product. Photo: DKT Mekong
Over the two days, the congress featured over 80 scientific reports and numerous in-depth practical workshops. Experts focused discussions on fetal medicine, high-risk pregnancies, minimally invasive laparoscopic surgery, and assisted reproduction. OGVFAP 2026 is recognized as a launchpad for highly practical medical initiatives, helping optimize treatment efficacy and shape women's healthcare strategies in Vietnam.
Thanh Thu
